Breaking News

PCI Pharma Services Expands UK Manufacturing Site

New facilities in Tredegar to offer innovative equipment and increased capacity to bring highly potent oncology therapies to market.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PCI Pharma Services (PCI), a global contract development and manufacturing organization (CDMO), is making a significant expansion of its facility in Tredegar, Wales, UK, to help keep pace with the market growth of oncology therapies. “We’re excited to announce the latest expansion in Tredegar that will address the growing and urgent need for specialty global manufacturing services within the oncology arena,” said Salim Haffar, CEO, PCI Pharma Services. “As the market expands for potent therap...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters